febuxostat has been researched along with silodosin in 2 studies
| Studies (febuxostat) | Trials (febuxostat) | Recent Studies (post-2010) (febuxostat) | Studies (silodosin) | Trials (silodosin) | Recent Studies (post-2010) (silodosin) |
|---|---|---|---|---|---|
| 818 | 133 | 710 | 317 | 74 | 211 |
| Protein | Taxonomy | febuxostat (IC50) | silodosin (IC50) |
|---|---|---|---|
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0901 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.0168 | |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.0019 | |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.3287 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0008 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 8.0716 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hussar, DA | 1 |
1 review(s) available for febuxostat and silodosin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for febuxostat and silodosin
| Article | Year |
|---|---|
New Drugs2010, PART 1.
Topics: Acetamides; Antibodies, Monoclonal; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Azepines; Benzazepines; Benzhydryl Compounds; Benzyl Alcohol; Benzylamines; Cyclams; Cyclopropanes; Drug Combinations; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Ethanolamines; Everolimus; Febuxostat; Fluorenes; Fluoroquinolones; Gout Suppressants; Heterocyclic Compounds; Humans; Immunosuppressive Agents; Indoles; Lacosamide; Milnacipran; Oligopeptides; Phenols; Selective Serotonin Reuptake Inhibitors; Sirolimus; Tapentadol; Thiazoles; Tolvaptan; Triazoles | 2010 |